Anti-Biofilm Wound Dressings Market
Number of pages: 100 | Report Format: PDF | Published date: April 12, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 735.4 million |
|
Revenue Forecast in 2031 |
US$ 1,584 million |
|
CAGR |
8.9% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Mechanism, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global anti-biofilm wound dressings market was valued at US$ 735.4 million in 2022 and is expected to register a revenue CAGR of 8.9% to reach US$ 1,584 million by 2031.
Anti-Biofilm Wound Dressings Market Fundamentals
Anti-biofilm wound dressings are specialized dressings designed to prevent and treat biofilm infections in wounds. Biofilms are complex communities of bacteria that can form on the surface of wounds, making them more difficult to treat and slowing down the healing process. Anti-biofilm wound dressings work through a variety of physical and chemical mechanisms to prevent and treat biofilm infections. Some dressings contain antimicrobial agents that help to kill bacteria and prevent them from forming biofilms. Other dressings may use silver or other metals to prevent biofilm formation and promote wound healing.
Anti-biofilm wound dressings are available in a variety of forms, including hydrocolloids, hydrogels, foam dressings, and antimicrobial dressings, among others. They may be used to manage both acute and chronic wounds, including surgical wounds, pressure ulcers, diabetic foot ulcers, and venous leg ulcers. Anti-biofilm wound dressings can help reduce the risk of infection and other complications in wounds, leading to faster healing and improved patient outcomes. They are an important part of advanced wound care and widely used in hospitals, clinics, and home healthcare settings.
[75686]
Anti-Biofilm Wound Dressings Market Dynamics
The growing incidence of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, is driving the demand for the global anti-biofilm wound dressings market. For instance, according to the National Center for Biotechnology Information article of May 2021, chronic wound affects nearly 2.5% of the total population of the U.S., disrupting their quality of life. Biofilm infections are a major cause of delayed wound healing and chronic infections. As a result, healthcare professionals and patients are increasingly aware of the importance of using anti-biofilm wound dressings. Additionally, the increasing demand for advanced wound care products, such as anti-biofilm wound dressings, is driven by the need for improved wound healing outcomes and reduced healthcare costs. Advances in wound care technology have led to the development of new and innovative anti-biofilm wound dressings that are more effective and easier to use than traditional wound dressings. Moreover, the rising healthcare expenditure in both developed and developing countries is driving the anti-biofilm wound dressings demand. Healthcare providers strive to improve patient outcomes and reduce healthcare costs, which is also helping in driving the revenue growth of the global anti-biofilm wound dressings market.
However, anti-biofilm wound dressings are generally more expensive than traditional ones, which can limit their adoption, particularly in low-income countries. Furthermore, the lack of reimbursement policies for advanced wound care products, including anti-biofilm wound dressings, can limit their adoption, particularly in countries with public healthcare systems. Additionally, limited awareness and education, lack of clinical evidence, and lengthy regulatory procedures are some restraints impeding the overall market revenue growth.
Anti-Biofilm Wound Dressings Market Ecosystem
The global anti-biofilm wound dressings market is analyzed from four perspectives: mechanism, application, end user, and region.
Anti-Biofilm Wound Dressings Market by Mechanism
[96766]
Based on the mechanism, the global anti-biofilm wound dressings market is segmented into physical, chemical, and biological mechanisms.
The chemical mechanism segment dominated the market with the largest revenue share in 2022, owing to its advantages in treating wounds. The chemical mechanism in anti-biofilm wound dressings involves using various chemicals or agents to prevent or eliminate biofilms in wounds. These agents can act through different mechanisms, such as disrupting the cell membranes of bacteria, interfering with their metabolic processes, or inhibiting their ability to form biofilms. Furthermore, antimicrobial agents are also used in anti-biofilms. These agents can kill or inhibit the growth of bacteria and other microorganisms. Examples of antimicrobial agents used in anti-biofilm wound dressings include silver, iodine, chlorhexidine, and polyhexamethylene biguanide (PHMB). For example, silver has been used for centuries as an antimicrobial agent and is effective against microbial growth. Silver ions can disrupt the cell membranes of bacteria, preventing them from replicating and forming biofilms. Additionally, enzymes are also used as chemicals in anti-biofilms. Enzymes can break down the extracellular matrix surrounding biofilms, making removing the biofilm easier and allowing antimicrobial agents to penetrate more effectively. Examples of enzymes used in anti-biofilm wound dressings include proteases and DNases. These aspects contribute to the chemical mechanism segment’s revenue growth.
The physical mechanism segment also accounts for a sizable revenue share in the global market. The physical mechanism in anti-biofilm wound dressings involves creating an unfavorable environment for bacteria to form and grow biofilms. These dressings physically block the bacteria from adhering to the wound surface, thereby preventing biofilm formation. There are multiple physical mechanisms, such as absorption, debridement, oxygenation, barrier function, and much more. Some dressings are designed to absorb exudate and other fluids from the wound, which can help to reduce the amount of moisture available for bacteria to form biofilms. Some dressings are designed to facilitate the removal of dead tissue and other debris from the wound bed, which can help to prevent biofilm formation by removing the bacteria’s food source. Additionally, physical mechanisms are often combined with other mechanisms, such as chemical mechanisms, to provide comprehensive protection against biofilm formation in wounds. Anti-biofilm wound dressings with physical modes of action can help improve wound healing outcomes and reduce the risk of complications associated with biofilm infections. These factors contribute to the revenue growth of the physical anti-biofilm wound dressings market.
Anti-Biofilm Wound Dressings Market by Application
Based on the application, the global anti-biofilm wound dressings market is segmented into chronic wounds and acute wounds.
The chronic wounds segment dominates the market with the largest revenue share, owing to the rising prevalence of chronic wounds among the population. Chronic wounds are particularly susceptible to biofilm formation, which can further delay the healing process and increase the risk of infection and other complications. Anti-biofilm wound dressings are essential to managing chronic wounds, as they can help prevent and treat biofilm infections and promote wound healing. Anti-biofilm wound dressings used for chronic wounds include products such as hydrocolloids, foam dressings, alginate dressings, and antimicrobial dressings.
The acute wounds segment is expected to be the fastest-growing segment throughout the forecast period. Acute wounds are typically caused by trauma or surgery and are expected to heal quickly, usually within a few weeks. Anti-biofilm wound dressings for acute wounds include a range of products such as hydrogels, hydrocolloids, foam dressings, and antimicrobial dressings, among others. These dressings work through different physical and chemical mechanisms to prevent and treat biofilm infections in acute wounds. Anti-biofilm wound dressings are an important part of managing acute wounds, as they can help prevent and treat biofilm infections and promote wound healing. These overall factors contribute to the revenue growth of the acute wounds segment.
Anti-Biofilm Wound Dressings Market by End User
Based on the end users, the global anti-biofilm wound dressings market is segmented into hospitals, specialty clinics, home healthcare, and others.
The hospital’s segment dominates the anti-biofilm wound dressings market, with the largest revenue share in 2022, attributed to hospitals being the primary healthcare setting for treating acute and chronic wounds. Hospitals are also a major source of demand for anti-biofilm wound dressings, as they treat many patients with various types of wounds. In hospitals, anti-biofilm wound dressings are typically used in wound care clinics, operating rooms, and inpatient settings such as intensive care and medical-surgical units.
The home healthcare segment is expected to be the fastest-growing segment in terms of revenue share during the forecast period. Patients often prefer to receive care at home, and anti-biofilm wound dressings can help to reduce the risk of infection and other complications, leading to faster healing and improved patient outcomes. Home healthcare providers may use anti-biofilm wound dressings to manage a variety of acute and chronic wounds, depending on the patient’s needs. Anti-biofilm wound dressings used in the home healthcare setting include products such as hydrocolloids, foam dressings, and antimicrobial dressings, among others. These dressings are often selected based on the type and severity of the wound, as well as the patient’s ability to manage the dressing at home. Patients often prefer to receive care at home, and anti-biofilm wound dressings can help to reduce the risk of infection and other complications, leading to faster healing and improved patient outcomes. These overall factors contribute to the revenue growth of the home healthcare segment.
Anti-Biofilm Wound Dressings Market by Region
Based on region, the global anti-biofilm wound dressings market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global anti-biofilm wound dressings market with the largest revenue share in 2022, attributed to the growing number of sports injuries, increased road accidents, and numerous major players. Additionally, companies across the region are continuously involved in partnerships, mergers, and acquisitions, which is also expected to improve the anti-biofilm wound dressings market outlook. For instance, in January 2023, Ampcontrol, an electrical engineering company, was awarded a grant worth US$ 5.6 million over three years by the federal government’s Cooperative Research Centers Projects (CRC-P) program, enabling them to collaborate with Whiteley Corporation on chronic wounds research. This joint project brings together a team comprising Whiteley Corporation, ResTech (a joint venture between Ampcontrol and the University of Newcastle), and Western Sydney University to create a comprehensive approach to wound care. Effective management of chronic wounds involves various treatments such as wound debridement, anti-biofilm treatment, wound mapping, and bacterial engagement perception beyond the wound surface, which cannot be easily detected.
Competitive Landscape of the Global Anti-Biofilm Wound Dressings
The prominent players operating in the global anti-biofilm wound dressings market are:
Strategic Developments in the Anti-Biofilm Wound Dressings
The global anti-biofilm wound dressings market was valued at US$ 735.4 million in 2022.
The expected size of the global anti-biofilm wound dressings market in 2031 is US$ 1,584 million.
The revenue CAGR of the anti-biofilm wound dressings market during the forecast period is expected to be 8.9% from 2023 to 2031.
The limited awareness and education, lack of clinical evidence, and lengthy regulatory procedures restrict the global anti-biofilm wound dressings market revenue growth to its full potential.
Some prominent players operating in the global anti-biofilm wound dressings market are Convatec Group Plc, Coloplast A/S, Lohmann & Rauscher GmbH & Co. KG, Urgo Medical, and Integra LifeSciences.
*Insights on financial performance are subject to the availability of information in the public domain